Effects of residual inflammatory and cholesterol risks on cardiovascular events with evolocumab in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Lipids Health Dis · 2025 · PMC11956451 · PMID 40165297

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Conversely, within each quartile of ANC, per-quartile increases in ALC were associated with a decreasing trend in the risk for these outcomes (Fig. 3 , Supplemental Tables 9 and 10).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.